Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Murakami M, Hirose E, Sato S, Ohkawa K, Ishizawa M, Yamaji H, Kawamura H, Kusachi S, Murakami T, Hina K, Ohe T. Hirohata A, et al. Among authors: hirohata s. J Am Coll Cardiol. 2010 Mar 9;55(10):976-82. doi: 10.1016/j.jacc.2009.09.062. J Am Coll Cardiol. 2010. PMID: 20202514 Free article. Clinical Trial.
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).
Hirohata A, Morino Y, Ako J, Sakurai R, Buchbinder M, Caputo RP, Karas SP, Mishkel GJ, Mooney MR, O'shaughnessy CD, Raizner AE, Wilensky RL, Williams DO, Wong SC, Yock PG, Honda Y, Moses JW, Fitzgerald PJ; DIRECT Investigators. Hirohata A, et al. Am J Cardiol. 2006 Dec 1;98(11):1464-7. doi: 10.1016/j.amjcard.2006.06.046. Epub 2006 Oct 12. Am J Cardiol. 2006. PMID: 17126651
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Hirose E, Kobayashi Y, Ohkawa K, Ohara M, Takafuji H, Sano F, Toyama Y, Kusachi S, Ohe T, Ito H. Hirohata A, et al. Among authors: hirohata s. Atherosclerosis. 2012 Jan;220(1):134-8. doi: 10.1016/j.atherosclerosis.2011.10.013. Epub 2011 Nov 9. Atherosclerosis. 2012. PMID: 22119063 Clinical Trial.
Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.
Miyoshi T, Hirohata A, Usui S, Yamamoto K, Murakami T, Komatsubara I, Kusachi S, Ohe T, Nakamura K, Ito H. Miyoshi T, et al. Among authors: hirohata a. Heart Vessels. 2014 Mar;29(2):178-85. doi: 10.1007/s00380-013-0343-0. Epub 2013 Apr 7. Heart Vessels. 2014. PMID: 23563752 Clinical Trial.
Impact of symptom presentation on in-hospital outcomes in patients with acute myocardial infarction.
Fujino M, Ishihara M, Ogawa H, Nakao K, Yasuda S, Noguchi T, Ozaki Y, Kimura K, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Ako J, Nakai M, Nishimura K, Miyamoto Y; J-MINUET Investigators. Fujino M, et al. Among authors: hirohata a. J Cardiol. 2017 Jul;70(1):29-34. doi: 10.1016/j.jjcc.2016.10.002. Epub 2016 Nov 14. J Cardiol. 2017. PMID: 27856131 Free article.
122 results